Multisite analytical evaluation of the abbott ARCHITECT cyclosporine assay

Therapeutic Drug Monitoring

Volumn 32, Issue 2, 2010, Pages 145-151

  Wallemacq, Pierre ^a   Maine, Gregory T ^b   Berg, Keith ^b   Rosiere, Thomas ^b   Marquet, Pierre ^c   Aimo, Giuseppe ^d   Mengozzi, Giulio ^d   Young, Julianna ^e   Wonigeit, Kurt ^f   Kretschmer, Robert ^g   Wermuth, Bendicht ^g   Schmid, Rainer W ^h  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b ABBOTT DIAGNOSTICS   (United States)

^c LIMOGES UNIVERSITY HOSPITAL   (France)

^d MOLINETTE HOSPITAL   (Italy)

^e FUJIREBIO INC   (Japan)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g UNIVERSITY OF BERN   (Switzerland)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cyclosporine; Immunoassay; LC MS MS; Method evaluation; Therapeutic drug monitoring

Indexed keywords

CYCLOSPORIN A; DRUG METABOLITE; CYCLOSPORIN;

ACCURACY; ARTICLE; AUTOMATION; CLINICAL LABORATORY; CONTROLLED STUDY; CROSS REACTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; EVALUATION; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ANTIBODY SPECIFICITY; BLOOD; CHEMICAL ANALYSIS; CLINICAL TRIAL; DRUG SCREENING; IMMUNOASSAY; MULTICENTER STUDY; PROCEDURES; STANDARDS;

ANTIBODY SPECIFICITY; CHEMISTRY TECHNIQUES, ANALYTICAL; CYCLOSPORINE; DRUG EVALUATION, PRECLINICAL; HUMANS; IMMUNOASSAY;

EID: 77950276474     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181d46386     Document Type: Article

References (25)

1. Andrews DJ, Crumb R. Cyclosporin: revisions in monitoring guidelines and review of current analytical methods. Ann Clin Biochem. 2002;39: 424-435.
2. Strassman MJ, Lensmeyer GL, Wiebe DA, et al. Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 1. Results with patient's specimens. Clin Chem. 1990;36:115-118.
3. McBride JH, Kim SS, Rodgerson DO, et al. Measurement of cyclosporine by liquid chromatography and three immunoassays from liver, cardiac and renal transplant recipients. Clin Chem. 1992;38:2300-2306.
4. Holman JW, Felder RA. Robotic automation of cyclosporine analysis in whole blood. Clin Chem. 1992;38:1440-1443.
5. Streit F, Armstrong VW, Oellerich M. Rapid liquid chromatography-tandem mass spectrometry method for simultaneous determination of sirolimus, tacrolimus and cyclosporine A in whole blood. Clin Chem. 2002;48:955-958.
6. Ciclosporin International Proficiency Testing Scheme. Available at: http:// www.bioanalytics.co.uk. Accessed September 2009.
7. Wang P, Meucci V, Simpson E, et al. A monoclonal antibody fluorescent polarization immunoassay for cyclosporine. Transplant Proc. 1990;22: 1186-1188.
8. Beresini MH, Davalian D, Alexander S, et al. Evaluation of EMIT cyclosporine assay for use with whole blood. Clin Chem. 1993;39: 2235-2241.
9. Schütz E, Svinarov D, Shipkova M, et al. Cyclosporine whole blood immunoassays (AxSYM, CEDIA and EMIT): a critical overview of performance characteristics and comparison with HPLC. Clin Chem. 1998;44:2158-2164.
10. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: How specific is specific? Clin Chem. 1999; 45:371-381.
11. Yatscoff RW, Copeland KR, Faraci CJ. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem. 1990;36:1969-1973.
12. Wallemacq PE, Alexandre K. Evaluation of the new AxSYM cyclosporine assay: Comparison with TDx monoclonal whole blood and EMIT cyclosporine assays. Clin Chem. 1999;45:432-435.
13. Terrell AR, Daly TM, Hock KG, et al. Evaluation of a no-Pretreatment cyclosporin A assay on the Dade Behring Dimension RxL clinical chemistry analyzer. Clin Chem. 2002;48:1059-1065.
14. National Committee for Clinical Laboratory Standards. Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline. 2nd ed. NCCLS document EP5-A2. Wayne, PA: NCCLS;2004.
15. Westgard JO. Basic Method Validation. 3rd ed. Madison, WI: Westgard QC Inc; 2008:168-174.
16. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem. 1983;21:709-720.
17. Schutz E, Streit F, Dias VC, et al. CsA immunoassays in comparison to LC-MS/MS, is there a difference between trough (C0) and C2 levels? Ther Drug Monit. 2001;23:A471.
18. Wallemacq P, Goffinet J, O'Morchoe S. et al. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. Ther Drug Monit. 2009;31:198-204.
19. Schmid R, Lotz J, Schweigert R, et al. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer. Clin Biochem. 2009;42: 1543-1548.
20. Wilson D, Sepe D, Barnes G, et al. Inter-laboratory differences in sirolimus results from six sirolimus testing centers using HPLC tandem mass spectrometry (LC/MS/MS). Clin Chim Acta. 2005;355:211-213.
21. Lensmeyer GL, Wiebe DA, Carlson IH.Identification and analysis of nine metabolites of cyclosporine in whole blood by liquid chromatography. 2: comparison of patients results. Clin Chem. 1987;33,1851-1855.
22. Oellerich M, Armstrong VW, Schütz E, et al. Therapeutic drug monitoring of cyclosporine and tacrolimus. Clin Biochem. 1998;31:309-316.
23. Jorga A, Holt DW, Johnston A. Therapeutic drug monitoring of cyclosporine. Transplant Proc. 2004;36(2S Suppl):S396-S403.
24. Soldin SJ, Steele BW, Witte D, et al. Lack of specificity of cyclosporine immunoassays\results of a College of American Pathologists Study. Arch Pathol Lab Med. 2003;127:19-22.
25. Holt DW, Denny K, Lee T, et al. Cyclosporin measurement\who cares about inaccuracy. Accred Qual Assur. 2001;6:405-408.